Daniel T. Richter

Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): Structure–activity relationships and strategies for the elimination of reactive metabolite formation

Daniel P. Walker, F. Christopher Bi, Amit S. Kalgutkar et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 51 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +9

Synthesis of Aryl Ethers via a Sulfonyl Transfer Reaction

Neal W. Sach, Daniel T. Richter, Stephan J. Cripps et al. · Organic Letters · 2012 · 37 citations

Cross-coupling Reaction, Aryl Ethers, Engineering +8

Selective addition of amines to 5-trifluoromethyl-2,4-dichloropyrimidine induced by Lewis acids

Daniel T. Richter, John C. Kath, Michael J. Luzzio et al. · Tetrahedron Letters · 2013 · 24 citations

Halogenation, Selective Addition, Organic Chemistry +4

Achieving selectivity between highly homologous tyrosine kinases: a novel selective erbB2 inhibitor

Samit K. Bhattacharya, Eric Cox, John C. Kath et al. · Biochemical and Biophysical Research Communications · 2003 · 19 citations

Signal Transduction, Functional Selectivity, Medicine +9